Clinical Trial Update: Lonafarnib in Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial update reports results for lonafarnib in metastatic breast cancer, with the study terminated and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Lonafarnib (lonafarnib)

Snippet

Sponsor: George Sledge | Conditions: Metastatic Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2016-02-18